BAX PHARMA, s.r.o.Active
Key figures
Key figures
2025Dividends
calculatedDistributed as dividends 10 530 340 € (100 % of distributable profit).
Balance sheet structure
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 25 699 891 | 29 739 442 | 39 319 049 | 44 886 078 | 60 643 452 |
| Profit for the reporting year | 2 379 950 | 2 589 741 | 3 704 704 | 4 235 981 | 4 562 890 |
| Retained earnings of previous periods | 6 393 021 | 8 772 971 | 3 855 598 | 6 294 359 | 0 |
| Total assets | 12 321 346 | 17 174 463 | 22 310 539 | 29 389 265 | 30 316 958 |
| Total liabilities | 3 541 071 | 5 804 447 | 14 668 643 | 18 850 675 | 25 743 046 |
| Total equity | 8 780 275 | 11 370 016 | 7 568 466 | 10 538 590 | 4 571 140 |
| Calculated dividends | 54 920 | 0 | 7 506 254 | 1 265 857 | 10 530 340 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements20
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2021 Správa audítora
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
Summary: BAX PHARMA, s.r.o.
Overview
BAX PHARMA, s.r.o. (IČO 35758481) is a limited liability company (s.r.o.). The company was incorporated in 1998 and has existed for 27 years. Registered office according to the register: Bratislava - mestská časť Staré Mesto. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 10–19 employees.
People
The statutory body has 3 members. According to the register, the company has one shareholder. The registered capital is 7 500 €.
Financial results
Revenue for 2025 was 60 643 452 €, up 35,1 % on the previous year (44 886 078 €). From 2020 to 2025, revenue grew by an average of 35,2 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 4 562 890 € (7,5 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 660 265 €. At the end of 2025 the company had total assets of 30 316 958 € and equity of 4 571 140 € (equity ratio 15,1 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 9. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.